NIAMS

North America, Maryland, United States, Bethesda

Description

NIAMS is a research institute that studies the causes, treatment, and prevention of arthritis, musculoskeletal and skin diseases

Investor Profile

NIAMS has backed more than 12 startups, with 1 new investments in the last 12 months alone. The firm has led 9 rounds, about 75% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

Concentrates on Grant rounds (top funding stages).
Majority of deals are located in United States, Trinidad and Tobago.
Strong thematic focus on Health Care, Biotechnology, Health Diagnostics.
Led 1 rounds in the past year.

Stage Focus

Grant (100%)

Country Focus

United States (92%)
Trinidad and Tobago (8%)

Industry Focus

Health Care
Biotechnology
Health Diagnostics
Life Science
Therapeutics
Pharmaceutical
Wellness
Neuroscience
Hardware
Information Technology

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does NIAMS frequently co-invest with?

National Institutes of Health

North America, Maryland, United States, Bethesda

Co-Investments: 4

What are some of recent deals done by NIAMS?

Myolex

Brookline, Massachusetts, United States

Quantified Assessment Of Muscle Health & Performance

Health CareHealth DiagnosticsMedical DeviceWellness

GrantAug 27, 2024

Amount Raised: $2,200,000

Fesarius Therapeutics

Brooklyn, New York, United States

Fesarius Therapeutics is to develop engineered skin replacement products.

BiotechnologyCosmeticsLife ScienceManufacturingSalesWellness

GrantAug 16, 2023

Amount Raised: $800,000

Zylö Therapeutics

Greenville, South Carolina, United States

Zylö Therapeutics offers an innovative sustained-release drug-delivery system.

Health CarePharmaceuticalTherapeutics

GrantMay 31, 2023

Amount Raised: $294,000

Amplo Biotechnology

Pompano Beach, Florida, United States

Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.

BiotechnologyHealth CareNeuroscienceTherapeutics

GrantMay 29, 2023

Icahn School of Medicine at Mount Sinai

New York, New York, United States

Icahn School of Medicine at Mount Sinai is a medical school located in New York.

GeneticsHealth CareMedical

GrantApr 3, 2023

Amount Raised: $1,300,000

Imbed Biosciences

Fitchburg, Wisconsin, United States

Imbed Biosciences is a Privately held medical device company.

BiometricsBiotechnologyHealth Care

GrantOct 14, 2021

Amount Raised: $800,000

Regenosine

New Jersey, Saint Patrick, Trinidad and Tobago

Regenosine is developing a disease-modifying regenerative therapy for osteoarthritis.

BiotechnologyHealth CarePharmaceutical

GrantOct 1, 2021

Amount Raised: $1,670,000

AAVogen

Rockville, Maryland, United States

AAVogen is a biotech startup that develops gene therapeutics for muscle wasting diseases.

Biotechnology

GrantSep 1, 2019

Amount Raised: $225,000

Cayman Chemical

Ann Arbor, Michigan, United States

Cayman Chemical is a biotechnology firm that provides assay kits, antibodies, proteins, biochemicals, and contract services.

BiotechnologyHealth CareLife Science

GrantApr 25, 2019

Amount Raised: $1,500,000

Bruin Biometrics

Los Angeles, California, United States

A pioneer in biometric-sensor based medical devices; committed to earlier diagnosis and targeted intervention for chronic conditions

HardwareHealth CareHealth DiagnosticsInformation TechnologymHealth

GrantDec 7, 2018

Amount Raised: $1,400,000

Find More Investors Like NIAMS

Discover similar investors in our database and build your perfect investor list.

grant Investors Investors in Bethesda Browse All Investors Top Investors

Need help with your fundraising strategy?Read our fundraising guides

NIAMS | Pipeseed